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Nitric oxide (NO)-stimulated cGMP synthesis is present
in the adult rat brain in close proximity to the NO-syn-
thase containing structures [1]. Intracellular cGMP con-
centration is under very precise control and depends on
parameters of its synthesis by guanylyl cyclase and degra-
dation by phosphodiesterases (PDE). It is known that in
the senescent brain the concentration of cGMP decreased
[2]. When brain slices were incubated in the presence of
isobutylmethylxanthine (IBMX), a nonselective phos-
phodiesterase inhibitor, sildenafil as a selective PDE5
inhibitor and BAY 60-7550 as a selective PDE2 inhibitor
and DEANONOate as an NO donor, we have previously
found that old brains are unresponsive to sildenafil treat-
ment. Therefore in this study we wanted to investigate
how the expression of cGMP selective phosphodiesterases
changes in the brain during aging by using mRNA in situ
hybridization.
Our results indicate differences in the expression of PDE 5
and 9 in the cerebral cortex, forebrain and caudate puta-
men during aging. Expression of PDE 5 is significantly
decreased in old brains in comparison to adult once,
which explains our previous findings with sildenafil.
Expression of PDE 9 is higher in old brains comparing to
adult and PDE 2 expression remains unchanged. Our
findings show that cGMP metabolism is altered during
brain aging.
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